Citadel Advisors’s Akili Inc AKLI Stock Holding History

Citadel Advisors’s Portfolio AKLI Stock Details AKLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,796	Closed	-$6.43K	–	15679
2024 Q2	$6.43K	Buy	+14,796	New	+$5.37K	﹤0.01%	13329
2023 Q1	–	Sell	-378	Closed	-$590	–	15746
2022 Q4	$423	Sell	378 -18,404	-98%	-$32.4K	﹤0.01%	14660
2022 Q3	$42K	Sell	18,782 -2,109,926	-99%	-$15.1M	﹤0.01%	11746
2022 Q2	$21.1M	Buy	2,128,708 +1,268	+0.1%	+$12.5K	0.01%	1800
2022 Q1	$21M	Buy	+2,127,440	New	+$21M	﹤0.01%	1930
2021 Q3	–	Sell	-250,000	Closed	-$2.53M	–	14876
2021 Q2	$2.53M	Buy	+250,000	New	+$2.53M	﹤0.01%	6013

Citadel Advisors's AKLI Position: Q3 2024 in Review

Citadel Advisors sold out of Akili Inc (AKLI) in Q3 2024, closing a stake of 14,796 shares — an estimated $6.43K sold.

Citadel Advisors first reported a position in AKLI in Q2 2021 and held it in 6 quarters. The position peaked at $21.1M in Q2 2022. 0 funds tracked by Wall St. Rank hold AKLI as of Q3 2024.

Citadel Advisors reported no remaining Akili Inc position as of Q3 2024 after selling out during the quarter.
Citadel Advisors sold 14,796 Akili Inc shares in Q3 2024, an estimated $6.43K.
Citadel Advisors first reported a position in Akili Inc in Q2 2021 and held it in 6 quarters.
Citadel Advisors's Akili Inc position peaked at $21.1M in Q2 2022.
0 funds tracked by Wall St. Rank held Akili Inc as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.